Harald Enzmann, MD, PhD

Experience in academic, corporate and regulatory settings. A physician by training (graduation 1985), MD “summa cum laude” from the Karl Ruprechts University, Heidelberg, Germany. Subsequent positions at the German Cancer Research Center, at the Institute of Pharmacology and Toxicology at the University of Erlangen, at R&D at Bayer AG, Wuppertal and at the American Health Foundation in Valhalla, NY, USA. Since 2002 Federal Institute for Drugs and Medical Devices (BfArM). Award of the German Cancer Research Center for Outstanding Research in 1987 and the Animal Welfare Research Award of the German Ministry of Health in 1995. Master of Science Degree for Experimental Pathology from the New York Medical College 1996, “Privatdozent” and venia legendi in Experimental Pathology from the University of Heidelberg in 1999. Associate Lecturer for Pharmaceutical Medicine and member of the Examination Board at the University Duisburg-Essen Fellow of the International Academy of Toxicologic Pathology, member of the European Society of Toxicological Pathology, of the Society of Toxicology and of the European Association for Cancer Research. Member of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) since 2005, Chair of CHMP since September 2108 .